Brianna Doby Johns Hopkins HOPE in Action Team

Slides:



Advertisements
Similar presentations
Health Law Curriculum Draft version. Country- GEORGIA Team Members: 1. Nina Kiknadze 1. Nina Kiknadze 2. Tiko Tsomaia 2. Tiko Tsomaia 3. Mamuka Djibuti.
Advertisements

Is Nucleic Acid Testing for Organ Donors the ‘Right’ Choice? Reference: Humara A, Morrisb M, Blumbergc R, et al. Nucleic acid testing (NAT) of organ donors:
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
HIV Organ Policy Equity (HOPE) Act Research Criteria: follow-up discussion Advisory Committee on Organ Transplantation April 13, 2015.
Organ Donation Dr Peter Bishop Clinical Lead for Organ Donation.
1 First Clinic Visit for Patients with HIV Infection HAIVN Harvard Medical School AIDS Initiative in Vietnam.
ART Program of the HIV Vaccine Trials Network Margaret Wecker, PhD Associate Director, Scientific Operations and Business Development.
Guidance for Recognizing Central Nervous System Infections in Potential Deceased Organ Donors: What to Consider During Donor Evaluation and Organ Offers.
Organ Donation. Over 106,000 Americans are on transplant waiting lists (4,500 in NJ) In 1988, 4,080 people donated organs after death. In 2008, that number.
Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Spring 2015.
OPTN OPTN/UNOS Ethics Committee Spring 2012 Regional Meeting Update Chair, Alexandra Glazier, MPH, JD Vice-Chair, Peter Reese, MD.
Dr. Igor Codreanu Center of Dialysis and Renal Transplant Republican Clinical Hospital, Chisinau THE IMPACT OF THE OVIEDO CONVENTION ON LEGISLATION IN.
Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Fall 2014.
Advisory Committee on Organ Transplantation (ACOT) November 17, 2015
Introduction Organ Transplantation Program Update Advisory Committee on Organ Transplantation November 17, 2015 Melissa Greenwald, MD Acting Director Division.
David A. Gerber, MD Professor and Chief Division of Abdominal Transplantation Department of Surgery University of North Carolina at Chapel Hill.
Transplantation in HIV+ Recipients Ron Shapiro, M.D. THOMAS E. STARZL TRANSPLANTATION INSTITUTE UNIVERSITY OF PITTSBURGH.
Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.
School of something FACULTY OF OTHER Leeds Institute of Medical Education School of Medicine Supporting Medical Educators Skills Day A CPD Event Dr Caitríona.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
Sources: Oyez, IIT Chicago-Kent School of Law, June, 2002; “Alexander, Murray Introduce Mental Health Awareness And Improvement Act,” The Chattanoogan,
Cadaveric vs Living Donation; Comparing Options
Federal Welcome: A View from the Office of HIV/AIDS and
Organ Failure in Nepal: Rapidly Growing Challenge for All
Policy Update Michael Ruppal Executive Director, The AIDS Institute
National Hepatitis C Database
3rd International HIV/Viral Hepatitis Co-Infection Meeting HIV/Viral Hepatitis: Improving Diagnosis, Antiviral Therapy and Access Sunday, 17 July.
Acceptability of early HIV treatment among South Africa women N Garrett, E Norman, V Asari, N Naicker, N Majola, K Leask, Q Abdool Karim and SS Abdool.
Attitude of HIV patients toward organ transplant between HIV patients: A Cross - Sectional questionnaire survey Dr H Taha [1], Dr Katie Newby [2], Mr.
GCP/QA SIAC Member Meeting 19 January 2007 Pamela Rose, Session Chair
Living Donor Transplants
NYHQ DSRIP Primary Care & Behavioral Health Committee Kick-Off Meeting
Pediatric Transplantation Committee
The Recipient Experience
UW Hospital and Clinics Organ Procurement Organization (OPO)
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
Expanding the Donation Opportunity:
A Federal Update and Perspective
Medical ethics – Organ donation
Community Advocacy & Education to End Stigmatizing HIV/TB Language
Liver Transplantation: 50 years
Organ, Eye and Tissue Donation in New York
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Clarify Informed Consent of Transmittable Conditions
Benefits of Renal Transplantation over Dialysis
Pediatric Transplantation Committee
Transitioning to Transplant
Thoracic Organ Transplantation Committee
Guidance for ABO Subtyping Organ Donors for Blood Groups A and AB
Region 9 Collaborative New York Academy of Medicine 3/20/18
Organ Procurement Organization Committee Report
Hepatitis C in the HIV-infected patient
Proposal to Require the Reporting of Aborted Living Donor Organ Recovery Procedures (Resolution 19) Living Donor Committee Mary Amanda Dew, PhD.
Thoracic Organ Transplantation Committee Spring 2019
Modify HOPE Act Variance to Include Other Organs
The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.
Retention: What It Means for You
Paediatric Donors and Transplant Patients
PROGRAMME 2: GOVERNANCE, POLICY & RESEARCH
Proposal to Delay the HCC Exception Score Assignment
Clarify Informed Consent of Transmittable Conditions
Kidney and Kidney/Pancreas Transplantation in a Year
Living Donor Committee
Living Donor Committee
Improving the Use of Medications to Treat Complex Health Problems in Resource-Poor Settings: Community-Based Examples from Haiti and Peru Jennifer Furin,
HIV Update, The OPO’s Perspective
Vascularized Composite Allograft (VCA) Transplantation Committee
Stakeholder engagement and research utilization: Insights from Namibia
25 May 2019 Emerging issues: The new Council of Europe Guide for the Quality and Safety of Organs for Transplantation 7th International Congress Infection.
Presentation transcript:

Brianna Doby Johns Hopkins HOPE in Action Team HOPE in North Carolina Brianna Doby Johns Hopkins HOPE in Action Team

HOPE: Powered by Partnerships Some of our partners from OPOs and TxC around the country

Christine Durand Assistant Professor, Johns Hopkins School of Medicine Division of Infectious Diseases, Transplant Oncology Group @CMDurandMD

Motivation/Significance In Europe and North America, HIV+ individuals who are taking their medications have a near-normal life expectancy and are no longer dying of AIDS, but rather of non-AIDS-related health conditions (Haidar Transplantation 2017) Prevalence of end stage kidney and liver disease in HIV+ individuals is increasing (Lucas CID 2014; Smith Lancet 2014) HIV+ transplant candidates have higher waitlist mortality compared to HIV- candidates (Trullas AIDS 2011, Ragni Liver Transpl 2005) Excellent outcomes with HIV- donor (HIV D-) organs for HIV+ recipients (HIV D-/R+) (Stock NEJM 2010, Roland AIDS 2016, Locke JASN 2015; Locke Transplantation 2016)

HOPE Act Implementation March -Lead sponsors established (Senators Boxer and Coburn; Representatives Capps and Harris) -Draft legislative language June -Meet with HHS and Office of National AIDS Policy -Congressional briefing Milestones in HOPE Act Implementation 2011-2017 January -First HOPE trial approved to evaluate the safety of HIV-to-HIV kidney and liver transplantation ClinicalTrials.gov NCT02602262 March  -First HIV-to-HIV kidney and liver transplants performed at JHU 1988: Use of HIV+ organs was made illegal 2011 2012 2013 2014 2015 2016 2017 February -HOPE Act conceived at Johns Hopkins University (JHU) March -HIV community endorsement April -Front page NY Times coverage June -Potential HIV+ donor pool estimated (study published in AJT) July -Official transplant community endorsement November -Official AMA endorsement February -HOPE Act introduced March -Congressional Budget Office scoring -Passes Senate HELP Committee June -Passes full Senate unanimously November -Passes House Energy & Commerce Committee -Passes full House unanimously -President Obama signs HOPE Act May -DHHS amends Final Rule to allow recovery of transplantable organs from HIV+ donors June -UNOS/OPTN institute policy changes and safety measures to allow for recovery and transplant of HIV+ donor organs for HIV+ recipients -Adoption of Final Rule change November -National Institutes of Health publishes HOPE Safeguard and Research Criteria to guide research for HIV+ organ transplantation July -U01 Award from NIAID HOPE in Action: A Multicenter Clinical Trial of HIV-to-HIV Deceased Donor Kidney Transplantation U01AI134591

Eligible Deceased Donor Criteria Per Federal HOPE Safeguards [14] No active invasive opportunistic complications of HIV infection Permissible under current criteria: HCV*, HBV co-infection Prior AIDS-defining illness Donation after cardiac death (DCD) Prior treated opportunistic infections Treatment naïve -No requirement: viral load -No requirement: CD4 count -Required: pre-implant donor organ biopsy -Required: description of effective post-transplant antiretroviral regimen for the recipient [14] Federal Register / Vol. 80, No. 227 / Wednesday, November 25, 2015 / Notices *HCV NAAT positive to NAAT negative transplants are not being done under the HOPE Act

Willingness to Donate Among the HIV+ Community 80% aware of organ shortage 24% aware of HOPE Act Persons who were unwilling to be donors Surgical concerns Concerns about life post-donation Concerns about HIV treatment post-donation 90% believed that HIV+ people should donate 73% believed this would reduce discrimination Nguyen…Durand et al, JAIDS 2018

Since 2000… People living with HIV who needed a transplant could be listed Those patients received transplants from HIV- organ donors Now, the HOPE Act permits living and deceased organ donation from HIV+ donors to HIV+ recipients

Every Patient Deserves HOPE “It is estimated that 1–2% of the 469,000 Americans on dialysis have HIV—so that means that the need for kidney transplant could be as high as 10,000.” “I couldn’t find a center that would list me for transplant. One doctor told me to go home and plan how to die.” – Gary Garcia

Nina Martinez First living kidney donor, also living with HIV, in the US Speaks publicly about breaking down HIV-related stigma “Don’t call me a hero, call me the first.”

Teaching the Public about HOPE Our outreach materials are intended to be culturally humble, not culturally competent. HIV+ deceased donation is new. Educating the public about HOPE is new. We have to approach education with humility—we may get some things wrong, but we’re learning.

Decreasing Stigma

So What? What materials would you like for yourself? What’s important for your clients to know? To have as resources? Is there a way our study team can better support professionals like you?

Thank You! bdoby1@jhmi.edu 303-246-0647 pos_rhetoric HopeTransplants.org